Randomized trial · people
Larazotide sped gut symptom recovery in children with post-COVID MISC
Checked against the paper Randomized trialPublished by PepVault
The takeaway
This is early evidence from a small trial in children that larazotide, used as an add-on for post-COVID MISC, caused no drug-related side effects and was tied to faster recovery.
- Kind
- Randomized trial
- Studied in
- People
- Number studied
- 12
- Published
- 2025
- Journal
- Sci Transl Med
What they tested
The team tested whether larazotide, given on top of standard care, is safe and helps children recover from multisystem inflammatory syndrome after COVID-19 (MISC).
How the study was done
A phase 2a randomized, double-blind, placebo-controlled trial in 12 children with MISC, median age 5.7 years, who joined while in the hospital. They took larazotide or a placebo (a dummy treatment) four times a day for 3 weeks on top of their usual care, with safety follow-up for 24 weeks.

What they found
No side effects linked to larazotide were seen. The amount of SARS-CoV-2 spike protein in the blood was correlated with inflammation markers, including interferon-γ (P = 0.004) and interleukin-6 (P < 0.0001), and with gut symptoms on the PedsQL GI symptom score, a questionnaire for children (P = 0.003). Children on larazotide had their gut symptoms settle sooner, cleared spike antigen from the blood faster and got back to their usual activities sooner.
What it doesn’t show
This was a very small, early-stage trial of 12 children, so its safety and benefit results are preliminary. The links between spike levels, inflammation and symptoms are correlations and don't show cause.
The paper
Yonker et al. Viral spike antigen clearance and augmented recovery in children with post-COVID multisystem inflammatory syndrome treated with larazotide. Sci Transl Med. 2025.
The compound
More studies on Larazotide
- Larazotide: eased GI symptoms in celiac patients on gluten challengeMeta-analysis · people · 2022
- Larazotide: 0.5 mg arm eased celiac symptoms on gluten-free dietRandomized trial · people · 2015
- Larazotide: no gut permeability rise after gluten in celiac patientsRandomized trial · people · 2007
- Larazotide lowered gut leakage in rats with acute pancreatitisAnimal study · rats · 2024
- Larazotide aided tight junction assembly in MDCK and Caco-2 cellsCell study · MDCK and Caco-2 cells · 2012
- Every study on Larazotide
Researched and drafted with AI, then checked claim by claim against the primary sources linked below by a separate review pass. Published by PepVault. Last reviewed . Spot an error? feedback@pepvault.app. How we research. This page reports one study; it is not medical advice.